Agtech investing has recently experienced a challenging period, with anticipated market consolidation and significant exits largely unfulfilled. Instead, companies prioritized securing capital to navigate a downturn, described as a “hangover” from previous excess funding. Mergers were difficult for financially weak entities. Despite these conditions, experts like David Pierson from Syngenta Group Ventures assert that agtech is not declining, noting a rise in innovation. Corporate Venture Capital firms are proving crucial, providing stable capital and deep sector knowledge. Pierson suggests 2026 will likely mark the bottom of this cycle. He identifies biocontrols, precision application, and artificial intelligence/machine learning tools for accelerating discovery, improving application, and enhancing operational efficiencies as key areas for future growth.
Source: Agtech isn’t dead, just sobering up, says Syngenta Group Ventures